News

Hexure's New Integration with DTCC Simplifies Can-Sell Process

Hexure's New Integration with DTCC Simplifies Can-Sell Process

Hexure Integrates with DTCC’s Producer Authorization

Hexure, a pioneering provider of sales and regulatory automation solutions tailored for the life and annuity sectors, has made significant strides in enhancing compliance and operational efficiency through its latest integration with The Depository Trust & Clearing Corporation's (DTCC) Producer Authorization (PAR) service. This innovative collaboration aims to streamline the can-sell process, making it easier for firms to verify producers' credentials and allow them to sell insurance products efficiently.

Benefits of Real-Time Compliance Check

In the fast-paced realm of financial services, ensuring compliance and efficiency is paramount. The integration of Hexure's FireLight, a robust digital sales platform, with DTCC's PAR enables users to perform real-time validations of an advisor's credentials and authorization to sell a specific product across various jurisdictions.

The Role of Standardized Processes

By adopting Hexure’s FireLight, distributors can utilize a unified, standardized approach that consolidates multiple licensing and appointment check systems into a seamless solution. This not only simplifies internal processes but significantly reduces the administrative burden that comes with maintaining various compliance checks. DTCC’s PAR service leverages API messaging capabilities to generate immediate responses, characterized by clear reason codes, enhancing responsiveness at the point of sale.

Elevating the Advisor Experience

One of the most compelling advantages of this integration is the ability for firms to confirm whether advisors meet the necessary licensing, appointments, registrations, and training requirements at the moment of sale. This advance greatly improves in-good-order application submissions, a critical factor in maintaining operational efficiency and a positive customer experience.

Insights from Industry Leaders

Kevin Pohmer, President of Hexure, expresses excitement over this milestone, stating, "Being the first order entry partner to integrate our platform with DTCC's PAR underscores our commitment to tackling industry challenges, particularly around not-in-good-order (NIGO) submissions. Our objective is to empower distributor clients with enhanced functionalities, allowing for quicker and simpler transactions for advisors."

Furthermore, the system is designed to allow advisors to proceed with sales while enforcing soft stops and have corrective measures in place. Hard stops will be initiated based on the advisor's authorization and credential status, ensuring compliance throughout the sales journey.

Enhanced Collaboration for Greater Efficiency

Justin Schwartz, Executive Director of Product Management for DTCC’s Wealth Management Services, highlights the collaboration's impact, stating, "Working with Hexure has enabled us to enhance compliance and efficiency significantly across distributors and carriers. Automating the can-sell check process at strategic points leads to improved submissions and overall operational deftness, ultimately benefitting both clients and advisors."

Company Profiles

About DTCC

DTCC stands as a cornerstone in post-trade market infrastructure, possessing over 50 years of experience in the global financial services landscape. With operations stemming from 20 global locations, DTCC specializes in automating, centralizing, and standardizing financial transaction processes, thereby enhancing transparency and driving efficiencies within the industry. In 2023 alone, DTCC processed securities transactions totaling a staggering U.S. $3 quadrillion, showcasing its pivotal role in maintaining the financial ecosystem.

About Hexure

Established in 1995, Hexure is celebrated for delivering digital sales solutions that specifically cater to the insurance, financial services, and wealth management sectors. Their products help carriers and distributors cultivate customer-focused sales experiences, expedite decision-making processes, minimize paper reliance, fulfill regulatory mandates, and enhance in-good-order sales outcomes. Hexure’s commitment to innovation and excellence continues to resonate throughout the industry, making it a trusted partner for many.

Frequently Asked Questions

What is the essence of Hexure's integration with DTCC?

Hexure's integration with DTCC’s Producer Authorization aims to streamline the can-sell process by allowing real-time verification of advisors' credentials and compliance.

How does the integration enhance operational efficiency?

By automating the can-sell check process at the point of sale, firms can quickly confirm if an advisor meets the necessary requirements without delays.

Who benefits from this integration?

Distributors, carriers, and financial advisors all gain from improved compliance processes, allowing for a more efficient sales workflow.

What role does API messaging play?

API messaging facilitates immediate responses regarding advisor credentials, enhancing the speed and accuracy of the verification process.

How has this integration been received in the industry?

Industry leaders have praised the collaboration for addressing long-standing challenges related to compliance and efficiency, highlighting its potential for significant impact.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 213

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 25

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 231

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 266

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 270

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 48

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading

Top 5 Most Recently Viewed Articles

VENU Embraces Blockchain: A New Era for Live Events

Updated Category News Views 203

VENU's Groundbreaking Blockchain Initiative in Live Entertainment In a significant move that signals the future of live entertainment, VENU (NYSE American: VENU), a leading operator of premium venues across the country, has announced an innovative blockchain-powered platform set to launch in 2026. This strategy is revolutionary, intending to blend physical experiences...

Continue Reading
Empowering Leadership Transitions at Ora Enhance Customer Focus

Updated Category News Views 144

Empowering Strategic Leadership at Ora Ora, an esteemed player in the field of ophthalmic contract research organizations (CROs), has recently appointed Cindy Markham as its new Chief Commercial Officer. This strategic move underscores Ora's dedication to enhancing the customer experience, setting a new benchmark in the ophthalmic research sector. Commitment to Customer...

Continue Reading
Real Matters Announces Online Annual General Meeting Details

Updated Category News Views 166

Virtual Annual General Meeting Scheduled for Shareholders Real Matters Inc., a prominent network management services provider, has announced the date for its upcoming Annual General Meeting (AGM). The meeting is set to take place on a Thursday morning, providing a convenient option for shareholders to participate from the comfort of their homes. Accessing the AGM Online...

Continue Reading
Trinity Biotech Triumphs in Nasdaq Compliance Journey

Updated Category News Views 41

Trinity Biotech Celebrates Nasdaq Compliance Achievement Trinity Biotech plc (Nasdaq Global Select: TRIB), a leading name in biotechnology focused on human diagnostics and diabetes management solutions, including innovative wearable biosensors, has reached a significant milestone. The company recently announced it has regained compliance with the minimum market value of...

Continue Reading
Vaycaychella Transitions to Great Estate Blockchains Inc

Updated Category News Views 176

Vaycaychella Unveils a Bold New Identity Vaycaychella, Inc. (OTC Pink: VAYK) has officially announced a name change to "Great Estate Blockchains Inc." This transition signifies a rejuvenated focus on enhancing the value of historic landmarks through innovative cryptocurrency strategies. The company aims to tap into a colossal market, potentially valued in the hundreds of...

Continue Reading